P

Inventor

SAKO DIANNE S

US26 patents
⚠️ This page may combine multiple inventors who share the name “SAKO DIANNE S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ACCELERON PHARMA INC

15 patents
US9809637B2Nov 7, 2017

Transforming growth factor beta receptor II fusion polypeptides

ACCELERON PHARMA INC19 citations92
US9975934B2May 22, 2018

Follistatin-related fusion proteins

ACCELERON PHARMA INC3 citations73
US10316076B2Jun 11, 2019

Transforming growth factor-beta receptor type II fusion polypeptides

ACCELERON PHARMA INC3 citations72
US12421295B2Sep 23, 2025

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

ACCELERON PHARMA INC0 citations62
US12195519B2Jan 14, 2025

Transforming growth factor-beta (TGF-beta) receptor type II fusion polypeptides

ACCELERON PHARMA INC0 citations62
US12054753B2Aug 6, 2024

Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers

ACCELERON PHARMA INC0 citations62
US12024563B2Jul 2, 2024

ALK7 antagonists and uses thereof

ACCELERON PHARMA INC0 citations62
US11440949B2Sep 13, 2022

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

ACCELERON PHARMA INC1 citations62
US11021527B2Jun 1, 2021

Transforming growth factor beta receptor type II fusion polypeptides

ACCELERON PHARMA INC0 citations62
US11008377B2May 18, 2021

Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides

ACCELERON PHARMA INC0 citations62
US11001614B2May 11, 2021

Method for treating a muscle-related disorder with follistatin-related fusion proteins

ACCELERON PHARMA INC1 citations62
US10981973B2Apr 20, 2021

Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide

ACCELERON PHARMA INC0 citations62
US10934532B2Mar 2, 2021

ALK4.ActRIIB heteromultimers

ACCELERON PHARMA INC0 citations62
US12168683B2Dec 17, 2024

Binders of TGFβ-superfamily ligands and uses thereof

ACCELERON PHARMA INC0 citations47
US12103959B2Oct 1, 2024

Multispecific binders of TGFBeta-superfamily ligands and uses thereof

ACCELERON PHARMA INC0 citations47

GENETICS INST

4 patents

GENETICS INST LLC

3 patents

BRIGHAM & WOMENS HOSPITAL INC

2 patents

INST GENETICS LLC

1 patent

LARSEN GLENN R

1 patent